This innovative technology, created at Stanford University in the US, is now being tested in Australia for the first time at the Chris O’Brien Lifehouse (Sydney), the Olivia Newton-John Cancer Centre (Melbourne), at PASO (Frankston), and ICON Cancer Centre (Adelaide).

Who can participate?

You must be over 18 with confirmed locally advanced or metastatic lung cancer, or another cancer that has metastases in the lung or liver. You cannot have begun treatment or must be off previous treatments for at least 30 days. You must live in Australia.

You can find detailed criteria and contact information in the official Australian New Zealand Clinical Trials Registry. Click and then scroll down to “Contacts,” email the Principal Investigator for trial participation inquiries.